Thiogenesis Therapeutics' MELAS Abstract Accepted for Late-Breaking News Presentation at Mitocon 2026Newsfile Corp • 01/13/26
Thiogenesis to Present Clinical Updates in MELAS and Leigh Syndrome Spectrum at UMDF Bench-to-Bedside WebinarNewsfile Corp • 01/05/26
Moomoo Partners with OTC Markets' MOON ATS® to Expand Its 24-Hour Trading for Retail InvestorsGlobeNewsWire • 12/03/25
Thiogenesis Therapeutics Expands on Plans for Phase 3 Pivotal Trial of TTI-0102 in Nephropathic CystinosisNewsfile Corp • 11/24/25
Here is Why Growth Investors Should Buy OTC Markets Group (OTCM) NowZacks Investment Research • 11/19/25